PATENT CLAIM ANALYSIS

Application Number: 16124111
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-08
Patent Classification: ["424", "482000"]

Abstract:
Disclosed are pharmaceutical compositions comprising Compound I, having the formula: and an effective amount of sofosbuvir wherein the sofosbuvir is substantially crystalline. Also disclosed are methods of use for the pharmaceutical composition.

Claim (Index 66):
The method of  claim 60 , wherein the patient is infected with hepatitis C virus of genotype 1.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 97.0
- Lexical Diversity: 1.24138
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15393847', '15670283', '15282128', '15885630', '14563639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7441786575679712
- 35 USC 102 Novelty (BERT): 0.5422631909458594
- Combined Prediction Score: 0.7239871109057601
- Mean Citation Score: 216.272936
- Max Citation Score: 254.84079
- Similarity Product: 147.00647349665164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test